Automation has become a pivotal force in the advancement of the biotech sector, ushering in a new era of AI-driven solutions. In this episode, I'm joined by David Williamson, the CIO at Abzena and a trailblazer in biotech innovation. We're peeling back the layers of AI integration, from commercial chatbots that defy the conventional, to AI's grip on scientific research.  All that, plus a dive into the pressing need for data governance and the critical role of innovative IT leadership in propelling the industry forward. Our exchange on the strategic incorporation of technology, and the necessary collaboration with tech giants, underlines the gravity of pursuing AI initiatives in biotech. So tune in, get inspired, and let's push the boundaries of what's possible in biotech together. Specifically, this episode highlights the following themes: Scalability and impact of AI chatbots for biotech firms.The enabling role of data governance in AI advancements.AI's influence on shortening drug development timelines.Links from this episode: Get to know more about Steven Swan: https://www.linkedin.com/in/swangroupGet to know more about David Williamson: https://abzena.com/about/leadership-team/david-williamsonLearn more about Abzena: https://abzena.com